Intuitive Surgical, Inc.  

(Public, NASDAQ:ISRG)   Watch this stock  
Find more results for isrg
-2.49 (-0.37%)
After Hours: 663.23 0.00 (0.00%)
Oct 27, 5:42PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 657.72 - 676.68
52 week 492.22 - 727.25
Open 667.49
Vol / Avg. 0.00/305,091.00
Mkt cap 25.18B
P/E 35.78
Div/yield     -
EPS 18.54
Shares 38.75M
Beta 0.72
Inst. own 94%
Oct 18, 2016
Q3 2016 Intuitive Surgical Inc Earnings Call - Webcast
Oct 18, 2016
Q3 2016 Intuitive Surgical Inc Earnings Release
Sep 14, 2016
Intuitive Surgical Inc at Morgan Stanley Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 27.53% 24.69%
Operating margin 36.62% 31.04%
EBITD margin - 34.79%
Return on average assets 13.35% 13.28%
Return on average equity 14.90% 15.30%
Employees 3,211 -
CDP Score - -


1020 Kifer Rd
SUNNYVALE, CA 94086-5301
United States - Map
+1-408-5232100 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation solution and three-dimensional (3-D), high-definition vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery procedures. Its da Vinci Surgery utilizes computational, robotic and imaging technologies. It focuses on five surgical specialties: gynecologic surgery, urologic surgery, general surgery, cardiothoracic surgery, and head and neck surgery.

Officers and directors

Lonnie M. Smith Independent Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gary S. Guthart Ph.D. President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Marshall L. Mohr Chief Financial Officer, Senior Vice President
Age: 60
Bio & Compensation  - Reuters
Salvatore J. Brogna Executive Vice President - Product Operations
Age: 61
Bio & Compensation  - Reuters
David J. Rosa Executive Vice President, Chief Commercial Officer
Age: 48
Bio & Compensation  - Reuters
Mark J. Meltzer Senior Vice President, Chief Compliance Officer, General Counsel
Age: 66
Bio & Compensation  - Reuters
Myriam J Curet M.D. Senior Vice President, Chief Medical Officer
Age: 59
Bio & Compensation  - Reuters
Colin Morales Senior Vice President - Manufacturing and Service Operations
Age: 52
Bio & Compensation  - Reuters
Jamie E. Samath Vice President, Corporate Controller, and Principal Accounting Officer
Age: 45
Bio & Compensation  - Reuters
Alan J Levy Lead Independent Director
Age: 78
Bio & Compensation  - Reuters